Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ACG Associated Capsules Pvt Ltd has now submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201115-06-2016
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
ACG Associated Capsules Pvt Ltd has now submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
ACG Associated Capsules Pvt Ltd has now submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011Outcome of Board Meeting
Wanbury Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2016, inter alia, has approved the following:1. Appointment of Mr. Rajesh Bahal as Director, Sales & Marketing - Formulation Division of the Company.2. Appointment of Mr. Vinod Verma as Chief Financial Officer of the Company.3. Issue of Shares on Preferential basis to Expert Chemicals (India) Pvt. Ltd., Promoters of the Company at Rs. 37.50/- as per CDR Scheme....Standalone & Consolidated Financial Results, Form B, Auditors Report for March 31, 2016
Wanbury Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form B for the period ended March 31, 20164. Consolidated Form B for the period ended March 31, 20165. Standalone Auditors Report for the period ended March 31, 20166. Consolidated Auditors Report for the period ended March 31, 2016Board Intimation for Results & Closure of Trading Window
Wanbury Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 18, 2016, inter alia, to consider and approve the Audited Financial Results for the last quarter and financial year ended March 31, 2016.Further, the trading window in respect of the Companys Securities shall remain closed for all Directors/Officers/Designated Employees of the Company from May 10, 2016 till May 20, 2016 as...Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Wanbury Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Shareholding for the Period Ended March 31, 2016
Wanbury Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click hereLimited Review Report for December 31, 2015
Wanbury Ltd has informed BSE about : 1. Standalone Limited Review for the period ended December 31, 2015Financial Results for December 31, 2015
Wanbury Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 2015